EGL ( EAGL) was climbing higher after main shareholder and CEO James Crane renewed his $36-a-share bid to take the freight company private, this time leading a group consisting of Centerbridge Partners and The Woodbridge Co.

Earlier this month shares of the Houston-based firm plunged after General Atlantic, Crane's former partner in the buyout offer, backed out in a reaction to soft fourth-quarter guidance. EGL also officially issued those weak numbers -- income of $10.9 million, or 27 cents a share, compared with $19.1 million, or 47 cents a share, last year. But EGL shares were rising $1.89, or 5.7%, to $35.36.

Novatel Wireless ( NVTL) said after the market close Tuesday that fourth-quarter non-GAAP profits rose to $4.4 million, or 14 cents a share, up from break-even last year. Revenue surged 58% to $77 million. The Street expected income at 6 cents a share on $76.1 million sales. The San Diego-based wireless-equipment maker was gaining 50 cents, or 3.9%, to $13.26.

Syniverse ( SVR), which sells services to the wireless-telecom industry, slid on dwindling profits. The Tampa, Fla., company posted adjusted fourth-quarter income of $11.5 million, or 17 cents a share, on sales that inched up 2.7% from last year to $85.8 million. Year-ago income came to $14.8 million, or 22 cents a share. Analysts were seeking 24 cents a share on $85.1 million in revenue.

Looking ahead, Syniverse expects 2007 sales of between $325 million and $335 million, at least $23 million under expectations. Shares were falling $2.17, or 15.5%, to $11.87.

Avanir Pharma ( AVNR) dropped on word it needs to provide the Food and Drug Administration with additional data supporting a lower-dosage formulation of Zenvia, its treatment for involuntary emotional expression disorder, a condition that can arise from a wide array of neurological diseases. The Aliso Viejo, Calif., company expects this will take about two years. Shares were losing 35 cents, or 15.6%, to $1.89.

PRA International ( PRAI) said earnings sank to $5.7 million, or 23 cents a share, including stock-option expenses and a one-off $1.7 million charge related to the resignation of CEO Patrick Donnelly. Last year the Reston, Va.-based company, which manages clinical trials and other research for biotechs and pharmaceuticals, earned $7.5 million, or 31 cents a share. Analysts projected per-share income at 29 cents. Sales totaled $92.5 million compared with $76.5 million a year ago, which tops the $81.7 million average estimate. Shares were shedding $3.06, or 13.3%, to $19.99.

Traffix ( TRFX) said earnings for the quarter ended Nov. 30 totaled only about $1,000, or break-even a share, compared with last year's gains of $781,000, or 5 cents a share. Revenue rose 3% year over year to $17.2 million, missing the $18.9 million called for by two analysts. Shares were dropping 73 cents, or 12.2%, to $5.25.

Salix Pharma ( SLXP) retreated after the Morrisville, N.C.-based company bought Merck's ( MRK) rights to gastrointestinal treatments Pepcid and Diuril for $55 million, plus $6 million in possible milestone fees. The company also said it borrowed $15 million on closing a new $100 million revolving credit facility last week. Despite better-than-expected fourth-quarter earnings of 29 cents a share, which reverses a 6-cent loss last year, Salix was off 85 cents, or 5.6%, to $14.25. Merck was recently up 86 cents, or 2%, to $44.04.

Audible ( ADBL), maker of digital spoken-word versions of books and other media, soared 21% on impressive fourth-quarter results . The Wayne, N.J.-based company narrowed its loss to $700,000, or 3 cents a share, compared with a year-ago loss of $2.2 million, or 9 cents a share. Wall Street was looking for a loss of 7 cents a share, according to Thomson Financial. Sales were also up 27.6% year over year to $23.3 million. Shares were adding $1.67 to $9.62.

Construction company Dycom Industries ( DY) climbed after seeing 40% higher fourth-quarter income to 14 cents a share, or $5.6 million, which edges past estimates by a penny. Revenue, at $258.3 million, just topped the consensus estimate. Shares of the Florida-based company were up $2.52, or 11.5%, to $24.38.

If you liked this article you might like

Lackluster Finish for U.S. Stocks

Lackluster Finish for U.S. Stocks

Stocks Continue to Waver at the Flat Line

Stocks Continue to Waver at the Flat Line

Oil Slides as Stocks Post a Mixed Showing

Oil Slides as Stocks Post a Mixed Showing

Stocks Flutter Near the Flat Line

Stocks Flutter Near the Flat Line

Wall Street Falls Amid Inflation Talk

Wall Street Falls Amid Inflation Talk